From Medscape Allergy & Immunology

Coverage from the

American Academy of Allergy, Asthma and Immunology Meeting (AAAAI)

March 03 - 06, 2017; Atlanta, GA

March 03 - 06, 2017 Atlanta, GA
  • AAAAI Immunotherapy Patch Desensitizes Peanut Allergy The vast majority of allergic patients do not want to eat peanuts, researchers report, but immunotherapy can help protect people if they do, 3-year data from the VIPES extension study show.
  • AAAAI Immunotherapy Showing Promise for Wheat Allergy Thirty percent of people who ate small amounts of wheat protein for 2 years achieved desensitization to the grain in a new oral immunotherapy study.
  • AAAAI More Black Children Die from Asthma, Study Confirms The mortality rate for black children with asthma is higher than for white or Hispanic kids. A decline in out-of-hospital deaths indicates some improvement in access to care, but questions remain.

Conference News

Popular News from AAAAI 2016

  • Antifungals May Relieve Asthma, Chronic Sinusitis Antifungals May Relieve Asthma, Chronic Sinusitis A new protocol for testing the sputum of patients with asthma or chronic sinusitis for fungus could help select those who will benefit from antifungal therapies, research shows.
  • Reslizumab Effective in Chronic Sinusitis With Nasal Polyps Reslizumab Effective in Chronic Sinusitis With Nasal Polyps For a subgroup of patients, an anti-interleukin-5 antibody improved asthma exacerbation rates, lung function, and quality of life, according to a subanalysis of data from two pivotal phase 3 trials.
  • Safety Data Accumulating for Combination Asthma Drugs Safety Data Accumulating for Combination Asthma Drugs The first of a series of safety studies mandated by the FDA suggests that the black-box warning on inhalers might not be warranted; however, patients with the most severe disease were excluded.

Medscape Allergy & Immunology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage